Warning
SpecGx Recalls Oxycodone and Acetaminophen CII Tablets USP
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0254-2026Drug / Pharmaceutical
SpecGx Recalls Oxycodone and Acetaminophen CII Tablets USP
SpecGx, LLC · Class II — Moderate Risk
Product Description
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Reason for Recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. SpecGx, LLC initiated the recall on December 16, 2025 affecting 287,988 Bottles. Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact SpecGx, LLC for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.